Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Rossi

Showing results (371-380 of 439) with videos related to

Pageof 44
Sort By:
Cancers|September 27, 2025
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open IssuesCaterina Alati, Martina Pitea, Matteo Molica, et al.
The Clinical Journal of Pain|February 2, 2013
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy centerMariangela Massaccesi, Francesco Deodato, Luciana Caravatta, et al.
International Journal of Cancer|April 11, 2025
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomasTiffanie Chouleur, Christèle Etchegaray, Laura Villain, et al.
Nature Communications|March 10, 2019
Deciphering the complex role of thrombospondin-1 in glioblastoma developmentThomas Daubon, Céline Léon, Kim Clarke, et al.
Blood|July 24, 2012
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myelomaSimona Blotta, Jana Jakubikova, Teresa Calimeri, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Cancers|February 6, 2020
The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli, Annamaria Gullà, Roberta Rocca, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
European Journal of Medicinal Chemistry|April 8, 2015
Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathwayArianna Nencini, Carmela Pratelli, Joanna M Quinn, et al.
Pageof 44

Showing results (371-380 of 439) with videos related to

Sort By:
Pageof 44
Cancers|September 27, 2025
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open IssuesCaterina Alati, Martina Pitea, Matteo Molica, et al.
The Clinical Journal of Pain|February 2, 2013
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy centerMariangela Massaccesi, Francesco Deodato, Luciana Caravatta, et al.
International Journal of Cancer|April 11, 2025
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomasTiffanie Chouleur, Christèle Etchegaray, Laura Villain, et al.
Nature Communications|March 10, 2019
Deciphering the complex role of thrombospondin-1 in glioblastoma developmentThomas Daubon, Céline Léon, Kim Clarke, et al.
Blood|July 24, 2012
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myelomaSimona Blotta, Jana Jakubikova, Teresa Calimeri, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Cancers|February 6, 2020
The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli, Annamaria Gullà, Roberta Rocca, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
European Journal of Medicinal Chemistry|April 8, 2015
Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathwayArianna Nencini, Carmela Pratelli, Joanna M Quinn, et al.
Pageof 44